Molecular BiologyNucleic Acids ResearchPeer-reviewed
IRF2BP2 counteracts the ATF7/JDP2 AP-1 heterodimer to prevent inflammatory overactivation in acute myeloid leukemia (AML) cells
Sabrina Fischer, Lisa Marie Weber, Bastian Stielow…·Robert Liefke
This study shows IRF2BP2 counteracts the ATF7/JDP2 AP-1 heterodimer to prevent excessive inflammation in AML cells, revealing a potential therapeutic target.
10 citations